Skip to main content
. 2022 Sep 21;17(9):e0274177. doi: 10.1371/journal.pone.0274177

Table 1. Characteristics of included studies.

First Author, Year Study Location Characteristics of Population Baseline Sample Size % Femalea Ageb Type of MBI Type of Control Group Delivery Method Guidance Number of Sessions Length of Intervention Measurements Type of Analysis Instrument of Outcome Measures
Online MBIs Control Depression Anxiety Stress
Alvarado-García et al., 2021 [32] Peru, America General population 30 30 N/A N/A MBSR Inactive (Waitlist) Videoconferencing With 8 sessions 8 weeks Post ITT N/A N/A PSS-10
Hosseinzadeh Asl, 2021 [33] Turkey, Asia Social workers 30 21 55.1 33.06 ± 6.02 MBCT Inactive (Waitlist) Videoconferencing With 4 sessions 4 weeks Post, 1-month follow-up PP DASS-21-D DASS-21-A DASS-21-S
Huang et al., 2021 [34] China, Asia Healthcare workers in COVID-19 isolation wards 58 60 77.1 32.27 ± 6.42 MBSR Active (Mental health education) Videoconferencing With 8 sessions 8 weeks Post ITT N/A N/A SRQ
Kam et al., 2021 [35] Canada, America University students 34 30 83.9 29.9 ± 8.8 MBCT Inactive (Waitlist) Mobile application Without 10 sessions 2 weeks Post PP PROMIS-D PROMIS-A N/A
Pheh et al, 2020 [36] Malaysia, Asia General population 104 79 73.9 28.75 ± 9.01 MBCT Active (Answering manipulated questions) Website Without 1 session 1 week Post, 2-week follow-up PP N/A GAD-7 SUDS
Simonsson et al., 2021 [37] England, Europe University students 88 89 64.4 23.27 ± 5.60 MBCT Inactive (Waitlist) Videoconferencing With 8 sessions 8 weeks Post, 1-month follow-up PP PROMIS-D PROMIS-A N/A
Smith et al., 2021 [38] United States, America Obstetrics and gynecology outpatients 50 51 100 36.21 ± 11.30 MBCT Inactive (Waitlist) Mobile application Without 4 sessions 4 weeks Post ITT HADS-D HADS-A PSS-10
Sun et al., 2021 [39] China, Asia University students 57 57 73.7 22.21 ± 2.67 MBSR and MBCT Active (Social support) Mobile application With 4 sessions 4 weeks Post, 2-month follow-up ITT PHQ-9 GAD-7 N/A

a% female of the total study population at baseline.

bMean and standard deviation of the study population age at baseline.

COVID-19, Coronavirus Disease 2019; DASS-21-A, Depression, Anxiety, and Stress Scale-21 Anxiety Subscale; DASS-21-D, Depression, Anxiety, and Stress Scale-21-Depression Subscale; DASS-21-S, Depression, Anxiety, and Stress Scale-21-Stress Subscale; GAD-7, Generalized Anxiety Disorder-7; HADS-A, Hospital Anxiety and Depression Scale-Anxiety Subscale; HADS-D, Hospital Anxiety and Depression Scale-Depression Subscale; ITT, intention-to-treat; MBCT, Mindfulness-Based Cognitive Therapy; MBI, mindfulness-based intervention; MBSR, Mindfulness-Based Stress Reduction; N/A, not available; PHQ-9, Patient Health Questionnaire-9; PP, per-protocol; PROMIS-A, Patient-Reported Outcomes Measurement Information System-Anxiety Subscale; PROMIS-D, Patient-Reported Outcomes Measurement Information System-Depression Subscale; PSS-10, Perceived Stress Scale-10; SD, standard deviation; SRQ, Stress Response Questionnaire; SUDS, Subjective Unit of Distress Scale.